GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson’s disease


Posted in: Drug Trial News | Medical Condition News

Tags: Brain, Cancer, Chronic Myeloid Leukemia, Clinical Trial, Dementia, Dopamine, Hospital, Leukemia, Movement disorders, Myeloid Leukemia, Neurodegeneration, Neurodegenerative Diseases, Neurology, New Drug Application, Nursing, Parkinson’s Disease, Placebo, Protein, Tyrosine